Dr. Linda Rhodes Joins Akston Biosciences' Board of Directors [Yahoo! Finance]
Zoetis Inc. Class A (ZTS)
Last zoetis inc. class a earnings: 2/13 07:00 am
Check Earnings Report
US:NYSE Investor Relations:
investor.zoetis.com
Company Research
Source: Yahoo! Finance
announced the appointment of Linda Rhodes, VMD, PhD to its Board of Directors. Dr. Rhodes brings Akston thirty years of experience in the animal health industry as a scientist, senior executive, and board member. Last month, Dr. Rhodes retired from the Board of Directors of Zoetis, Inc., having served there since 2017. She was the founding CEO of Aratana Therapeutics, where she grew the company, and led the development and FDA approval of three drugs in five years — Galliprant, Entyce and Nocita. When the company became publicly traded, she assumed the role of Chief Scientific Officer. In 2001, she founded AlcheraBio, a contract research firm dedicated to helping bring new animal drugs to market, which was acquired by Argenta in 2008. She served on the Board of the Alliance for Contraception in Cats and Dogs from 2008-2023. As a member of the Scientific Advisory Board of the Michelson Prize and Grants, Dr. Rhodes has worked to facilitate the discovery of a single injection treatme
Show less
Read more
Impact Snapshot
Event Time:
ZTS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ZTS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ZTS alerts
High impacting Zoetis Inc. Class A news events
Weekly update
A roundup of the hottest topics
ZTS
News
- Zoetis Foundation and Zoetis Deepen Commitment to Global Disaster Relief with American Red Cross and American Humane [Yahoo! Finance]Yahoo! Finance
- Zoetis Foundation and Zoetis Deepen Commitment to Global Disaster Relief with American Red Cross and American HumaneBusiness Wire
- The Schall Law Firm Launches Probe Into Allegations Against Zoetis Inc And Encourages Investors With Losses To Reach OutAccesswire
- Veterinary Oncology Market to Hit $1,563.7 Million by 2031, at a CAGR of 11.6%, says Coherent Market Insights [Yahoo! Finance]Yahoo! Finance
- The Schall Law Firm Initiates Investigation Into Claims Against Zoetis Inc And Urges Investors With Losses To Make ContactAccesswire
ZTS
Earnings
- 5/2/24 - Beat
ZTS
Sec Filings
- 5/30/24 - Form SD
- 5/24/24 - Form 8-K
- 5/23/24 - Form 8-K
- ZTS's page on the SEC website